Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
Apyx Medical (NASDAQ:APYX) announced that President and CEO Charles Goodwin and CFO Matt Hill will attend the 15th Annual Craig-Hallum Alpha Select Conference. The event will take place on November 19, 2024, at the Sheraton NY Times Square Hotel in New York, NY, featuring 1x1 meetings format.
Apyx Medical is an advanced energy technology company specializing in Helium Plasma Platform Technology products, marketed as Renuvion in cosmetic surgery and J-Plasma in hospital surgical markets. Their technology provides surgeons with controlled heat tissue treatment capabilities, supported by over 90 clinical documents.
Apyx Medical (NASDAQ:APYX) ha annunciato che il Presidente e CEO Charles Goodwin e il CFO Matt Hill parteciperanno alla 15ª Conferenza Annuale Craig-Hallum Alpha Select. L'evento si svolgerà il 19 novembre 2024 presso il Sheraton NY Times Square Hotel a New York, NY, utilizzando un formato di incontri 1x1.
Apyx Medical è un'azienda di tecnologia avanzata che si specializza in prodotti di tecnologia della piattaforma al plasma di elio, commercializzati come Renuvion nella chirurgia estetica e J-Plasma nei mercati chirurgici ospedalieri. La loro tecnologia fornisce ai chirurghi la possibilità di un trattamento controllato del tessuto mediante calore, supportata da oltre 90 documenti clinici.
Apyx Medical (NASDAQ:APYX) anunció que el Presidente y CEO Charles Goodwin y el CFO Matt Hill asistirán a la 15ª Conferencia Anual Craig-Hallum Alpha Select. El evento se llevará a cabo el 19 de noviembre de 2024 en el Sheraton NY Times Square Hotel en Nueva York, NY, con un formato de reuniones 1x1.
Apyx Medical es una empresa de tecnología avanzada que se especializa en productos de Tecnología de Plataforma de Plasma de Helio, comercializados como Renuvion en cirugía estética y J-Plasma en los mercados quirúrgicos hospitalarios. Su tecnología proporciona a los cirujanos capacidades de tratamiento de tejidos con calor controlado, respaldada por más de 90 documentos clínicos.
Apyx Medical (NASDAQ:APYX)는 회장 겸 CEO인 Charles Goodwin과 CFO인 Matt Hill이 제15회 Craig-Hallum Alpha Select 콘퍼런스에 참석할 것이라고 발표했습니다. 이 행사는 2024년 11월 19일 뉴욕의 Sheraton NY Times Square Hotel에서 진행되며, 1대1 회의 형식을 특징으로 합니다.
Apyx Medical은 헬륨 플라즈마 플랫폼 기술 제품을 전문으로 하는 첨단 에너지 기술 회사로, 미용 수술에서는 Renuvion으로, 병원 수술 시장에서는 J-Plasma로 판매됩니다. 이 기술은 외과의사에게 통제된 열 조직 치료 능력을 제공하며, 90개 이상의 임상 문서에 의해 뒷받침됩니다.
Apyx Medical (NASDAQ:APYX) a annoncé que le Président et CEO Charles Goodwin ainsi que le CFO Matt Hill participeront à la 15ème Conférence Annuelle Craig-Hallum Alpha Select. L'événement aura lieu le 19 novembre 2024 à l'Hôtel Sheraton NY Times Square à New York, NY, avec un format de réunions en tête-à-tête.
Apyx Medical est une entreprise de technologie avancée spécialisée dans les produits de technologie de plateforme à plasma d'hélium, commercialisés sous le nom de Renuvion en chirurgie esthétique et J-Plasma dans les marchés chirurgicaux hospitaliers. Leur technologie offre aux chirurgiens des capacités de traitement des tissus par chaleur contrôlée, soutenues par plus de 90 documents cliniques.
Apyx Medical (NASDAQ:APYX) gab bekannt, dass Präsident und CEO Charles Goodwin sowie CFO Matt Hill an der 15. jährlichen Craig-Hallum Alpha Select-Konferenz teilnehmen werden. Die Veranstaltung findet am 19. November 2024 im Sheraton NY Times Square Hotel in New York, NY, im Format von 1x1-Meetings statt.
Apyx Medical ist ein Unternehmen für fortschrittliche Energietechnologie, das sich auf Produkte der Helium-Plasma-Plattformtechnologie spezialisiert hat, die als Renuvion in der kosmetischen Chirurgie und als J-Plasma in den chirurgischen Märkten von Krankenhäusern vermarktet werden. Ihre Technologie bietet Chirurgen die Möglichkeit einer kontrollierten Wärmebehandlung von Geweben, unterstützt durch über 90 klinische Dokumente.
- None.
- None.
CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conference:
Event: 15th Annual Craig-Hallum Alpha Select Conference
Date: November 19, 2024
Location: Sheraton NY Times Square Hotel, New York, NY
Format: 1x1 Meetings
To request a meeting with Apyx, investors should contact their Craig Hallum representative.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
Investor Relations Contact:
Jeremy Feffer, Managing Director LifeSci Advisors
OP: 212-915-2568
jfeffer@lifesciadvisors.com
FAQ
When is Apyx Medical (APYX) attending the Craig-Hallum Alpha Select Conference in 2024?
What are the main products of Apyx Medical (APYX)?
How many clinical documents support Apyx Medical's (APYX) Renuvion and J-Plasma products?
Which Apyx Medical (APYX) executives will attend the 2024 Craig-Hallum Conference?
